Research reveals the presence of bisphenol A (BPA) analogues and alternatives in human breast milk, raising concerns for infant health and developmental impacts.
Bisphenols, known for endocrine-disrupting properties, are widely used in plastics and consumer goods, posing a risk to hormonal systems.
Advanced screening methods detected a range of bisphenol analogues in breast milk, highlighting the need for comprehensive toxicological assessments.
The study compared milk samples from Canada and South Africa, revealing widespread contamination by bisphenol structural analogues in both regions.
Endocrine disruptors like bisphenols can impact gene expression, cellular signaling, and developmental processes during critical life stages.
Technological advancements in suspect screening enable the identification of unknown compounds in human milk, enhancing exposure science.
Risk assessment of bisphenol substitutes, often marketed as safer alternatives, is crucial in light of their potential comparable toxicological profiles.
Public health initiatives are needed to educate on sources of bisphenol exposure, advocate for safer consumer choices, and promote chemical transparency.
Longitudinal studies correlating bisphenol levels in breast milk with child health outcomes are essential to understand the impact of exposure.
Collaboration among disciplines is key to elucidating risks and developing mitigation strategies for bisphenol contamination in human biological systems.